trending Market Intelligence /marketintelligence/en/news-insights/trending/Ku0zTJUFgPj2JS73y2Gu9w2 content esgSubNav
In This List

Seattle Genetics director resigns

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Seattle Genetics director resigns

John McLaughlin resigned as a director of Seattle Genetics Inc. to focus on his responsibilities as president and CEO of PDL BioPharma Inc., effective Dec. 16.

Following McLaughlin's resignation, Daniel Welch was appointed to the board's audit committee.

Welch is an independent director of Seattle Genetics.